Archives for January 15, 2009

← 2009

Pressured Cel-Sci may turn to contract manufacturing

By Phil Taylor

US biotechnology company Cel-Sci is hoping to offer contract manufacturing to pharmaceutical partners from its new facility in Baltimore, as it tries to raise money to support the clinical development of its cancer immunotherapy Multikine.

Asian pack machine demand a boon US and EU industry

By Gareth Macdonald

The market for packaging machinery is set to grow 5 per cent a year and be worth $40bn (€30.3bn) by 2012, driven partly by a hike in demand for drug products in “pharmerging” economies, according to a new industry report.

inVentive consolidates New Jersey HQ

By Gareth Macdonald

Drug contract services specialist inVentive Health has selected a new office in Somerset, New Jersey, US which will house its patient outcomes, clinical, health and commercial division.

Trial complexity a headache for IRBs

By Nick Taylor

The rise in international, multi-centre clinical trials has complicated reporting pathways and led to institutional review boards (IRBs) being overloaded with adverse events, according to FDA guidance.

Ash Stevens invests in parallel synthesis

By Phil Taylor

US contract manufacturer Ash Stevens Inc has upgraded its active pharmaceutical ingredient (API) facility in Riverview, Michigan, with new equipment for parallel synthesis and calorimetry.

FDA launches global supply chain pilot scheme

By Gareth Macdonald

In the latest part of its “beyond our borders” scheme, the US FDA is asking drugmakers to volunteer supply chain information for drugs and APIs sourced outside the USA.